Baxter, Ethicon and Integra lead the way...As reported in SmartTRAK’s Financial Dashboard, the US market for Hemostats and Sealants grew +3.8% YoY in Q218, an increase from +3.1% growth rate overall in Q118. Fibrin sealants continue to lead the way with +7.2% YoY growth in Q218, and thrombin hemostats had a very good quarter with +7.2% growth YoY...
Among the many topics covered in the full Q218 Hemostats and Sealants Market Recap are:
- Ethicon Continues to Lead Hemostats and Sealants
- Thrombins Come Back In Hemostats
- Fibrin Continues To Shine In Sealants
- Q218 events in the US Hemostats and Sealants Market
In Q218, Ethicon continued to lead the overall US Hemostats and Sealants market, again outpacing the overall market at +5.3% YoY and a 43.8% share. Baxter processed its acquisition of most of Mallinckrodt’s hemostasis portfolio and rocketed up +22.8% YoY and a 27.1% market share...
*This article can only be viewed by SmartTRAK subscribers to this module. For information on how to subscribe, please click the button below.